These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9797772)

  • 1. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
    Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
    Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
    Salama ME; Worsham MJ; DePeralta-Venturina M
    Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
    Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
    Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
    Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
    Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p.
    Füzesi L; Gunawan B; Bergmann F; Tack S; Braun S; Jakse G
    Histopathology; 1999 Aug; 35(2):157-61. PubMed ID: 10460661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
    Amo-Takyi BK; Mittermayer C; Günther K; Handt S
    Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
    Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
    J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.
    Hadaczek P; Podolski J; Toloczko A; Kurzawski G; Sikorski A; Rabbitts P; Huebner K; Lubinski J
    Virchows Arch; 1996 Sep; 429(1):37-42. PubMed ID: 8865851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
    J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
    Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
    Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics.
    Rigola MA; Casadevall C; Bernués M; Caballín MR; Fuster C; Gelabert A; Egozcue J; Miró R
    Cancer Genet Cytogenet; 2002 Aug; 137(1):49-53. PubMed ID: 12377413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.